{
  "CB1": {
    "name": "CB1",
    "type": "checkbox",
    "page": 2,
    "field_label": "Start of treatment",
    "question": "Is this a new treatment start for the patient?",
    "context": "Initial checkbox in treatment timeline section indicating whether patient is beginning new therapy versus continuing existing treatment."
  },
  "T2": {
    "name": "T2",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (MM)",
    "question": "What is the month of treatment start?",
    "context": "2-digit month format for planned medication initiation date in treatment scheduling section."
  },
  "T3": {
    "name": "T3",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (DD)",
    "question": "What is the day of treatment start?",
    "context": "2-digit day format for planned medication initiation date in treatment scheduling section."
  },
  "T4": {
    "name": "T4",
    "type": "text",
    "page": 2,
    "field_label": "Start date: (YYYY)",
    "question": "What is the year of treatment start?",
    "context": "4-digit year format for planned medication initiation date in treatment scheduling section."
  },
  "CB5": {
    "name": "CB5",
    "type": "checkbox",
    "page": 2,
    "field_label": "Continuation of therapy",
    "question": "Is this a continuation of an existing therapy for the patient?",
    "context": "Indicates if the request is for ongoing treatment, requiring details of the last administration date."
  },
  "T6": {
    "name": "T6",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (MM)",
    "question": "What is the month of the last treatment?",
    "context": "2-digit month for the most recent administration of the medication being continued."
  },
  "T7": {
    "name": "T7",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (DD)",
    "question": "What is the day of the last treatment?",
    "context": "2-digit day for the most recent administration of the medication being continued."
  },
  "T8": {
    "name": "T8",
    "type": "text",
    "page": 2,
    "field_label": "Date of last treatment: (YYYY)",
    "question": "What is the year of the last treatment?",
    "context": "4-digit year for the most recent administration of the medication being continued."
  },
  "T9": {
    "name": "T9",
    "type": "text",
    "page": 2,
    "field_label": "Precertification Requested By:",
    "question": "Who is requesting this precertification?",
    "context": "Name of the individual submitting the precertification request on behalf of the patient/provider."
  },
  "T10": {
    "name": "T10",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number of the precertification requestor?",
    "context": "Contact phone number for the person designated as the precertification requestor."
  },
  "T11": {
    "name": "T11",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number of the precertification requestor?",
    "context": "Contact fax number for the person designated as the precertification requestor."
  },
  "T12": {
    "name": "T12",
    "type": "text",
    "page": 5,
    "field_label": "Patient First Name",
    "question": "What is the patient's first name?",
    "context": "Patient demographic information for identification purposes in the patient information section."
  },
  "T13": {
    "name": "T13",
    "type": "text",
    "page": 5,
    "field_label": "Patient Last Name",
    "question": "What is the patient's last name?",
    "context": "Patient demographic information for identification purposes in the patient information section."
  },
  "T14": {
    "name": "T14",
    "type": "text",
    "page": 5,
    "field_label": "Patient DOB (MM/DD/YYYY)",
    "question": "What is the patient's date of birth?",
    "context": "Patient demographic information to verify identity and age in the patient information section."
  },
  "T15": {
    "name": "T15",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the patient's street address?",
    "context": "Patient's primary residential address for demographic and communication purposes."
  },
  "T16": {
    "name": "T16",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the patient's city?",
    "context": "Patient's residential city, part of demographic and contact information."
  },
  "T17": {
    "name": "T17",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the patient's state?",
    "context": "Patient's residential state, part of demographic and contact information."
  },
  "T18": {
    "name": "T18",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the patient's ZIP code?",
    "context": "Patient's residential ZIP code, part of demographic and contact information."
  },
  "T19": {
    "name": "T19",
    "type": "text",
    "page": 5,
    "field_label": "Patient Phone",
    "question": "What is the patient's phone number?",
    "context": "Patient contact information for communication in the patient information section."
  },
  "T20": {
    "name": "T20",
    "type": "text",
    "page": 2,
    "field_label": "Work Phone:",
    "question": "What is the patient's work phone number?",
    "context": "Secondary contact number for the patient, used for business hours contact."
  },
  "T21": {
    "name": "T21",
    "type": "text",
    "page": 2,
    "field_label": "Cell Phone:",
    "question": "What is the patient's cell phone number?",
    "context": "Mobile contact number for the patient, typically for direct and urgent communications."
  },
  "T22": {
    "name": "T22",
    "type": "text",
    "page": 2,
    "field_label": "E-mail:",
    "question": "What is the patient's email address?",
    "context": "Electronic contact information for the patient, for digital correspondence."
  },
  "T24": {
    "name": "T24",
    "type": "text",
    "page": 2,
    "field_label": "lbs",
    "question": "What is the patient's current weight in pounds?",
    "context": "Patient's current weight in pounds, critical for accurate medication dosing calculations."
  },
  "T25": {
    "name": "T25",
    "type": "text",
    "page": 2,
    "field_label": "kgs",
    "question": "What is the patient's current weight in kilograms?",
    "context": "Patient's current weight in kilograms, critical for accurate medication dosing calculations."
  },
  "T26": {
    "name": "T26",
    "type": "text",
    "page": 2,
    "field_label": "inches",
    "question": "What is the patient's current height in inches?",
    "context": "Patient's current height in inches, used for body surface area calculations for dosing."
  },
  "T27": {
    "name": "T27",
    "type": "text",
    "page": 2,
    "field_label": "cms",
    "question": "What is the patient's current height in centimeters?",
    "context": "Patient's current height in centimeters, used for body surface area calculations for dosing."
  },
  "T23": {
    "name": "T23",
    "type": "text",
    "page": 2,
    "field_label": "Allergies:",
    "question": "What known allergies does the patient have?",
    "context": "Crucial safety information regarding patient's allergies to ensure medication safety."
  },
  "T28": {
    "name": "T28",
    "type": "text",
    "page": 2,
    "field_label": "Member ID #:",
    "question": "What is the patient's insurance member ID number?",
    "context": "Primary identifier for the patient under their insurance policy for eligibility verification."
  },
  "T29": {
    "name": "T29",
    "type": "text",
    "page": 2,
    "field_label": "Group #:",
    "question": "What is the patient's insurance group number?",
    "context": "Identifies the specific insurance group or plan under which the patient is covered."
  },
  "T30": {
    "name": "T30",
    "type": "text",
    "page": 2,
    "field_label": "Insured:",
    "question": "Who is the primary insured party for this policy?",
    "context": "Name of the primary policyholder, especially if different from the patient."
  },
  "CB31": {
    "name": "CB31",
    "type": "checkbox",
    "page": 2,
    "field_label": "Yes",
    "question": "Does the patient have other health coverage?",
    "context": "Determines if secondary insurance information is required for coordination of benefits."
  },
  "CB32": {
    "name": "CB32",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Does the patient have no other health coverage?",
    "context": "Indicates the absence of secondary insurance coverage for the patient."
  },
  "T33": {
    "name": "T33",
    "type": "text",
    "page": 2,
    "field_label": "If yes, provide ID#:",
    "question": "If other coverage exists, what is the ID number?",
    "context": "Member ID for the patient's secondary insurance policy, if applicable."
  },
  "T34": {
    "name": "T34",
    "type": "text",
    "page": 2,
    "field_label": "Carrier Name:",
    "question": "What is the name of the other insurance carrier?",
    "context": "Name of the secondary insurance company, if the patient has additional coverage."
  },
  "T35": {
    "name": "T35",
    "type": "text",
    "page": 2,
    "field_label": "Insured:",
    "question": "Who is the primary insured party for the other policy?",
    "context": "Name of the primary policyholder for the patient's secondary insurance, if applicable."
  },
  "T42": {
    "name": "T42",
    "type": "text",
    "page": 2,
    "field_label": "First Name:",
    "question": "What is the prescriber's first name?",
    "context": "Prescriber's first name for proper identification and record-keeping."
  },
  "T43": {
    "name": "T43",
    "type": "text",
    "page": 2,
    "field_label": "Last Name:",
    "question": "What is the prescriber's last name?",
    "context": "Prescriber's last name for proper identification and record-keeping."
  },
  "CB44": {
    "name": "CB44",
    "type": "checkbox",
    "page": 2,
    "field_label": "M.D.",
    "question": "Is the prescriber an M.D. (Medical Doctor)?",
    "context": "Indicates the professional designation of the prescribing physician."
  },
  "CB45": {
    "name": "CB45",
    "type": "checkbox",
    "page": 2,
    "field_label": "D.O.",
    "question": "Is the prescriber a D.O. (Doctor of Osteopathic Medicine)?",
    "context": "Indicates the professional designation of the prescribing physician."
  },
  "CB46": {
    "name": "CB46",
    "type": "checkbox",
    "page": 2,
    "field_label": "N.P.",
    "question": "Is the prescriber an N.P. (Nurse Practitioner)?",
    "context": "Indicates the professional designation of the prescribing advanced practice nurse."
  },
  "CB47": {
    "name": "CB47",
    "type": "checkbox",
    "page": 2,
    "field_label": "P.A.",
    "question": "Is the prescriber a P.A. (Physician Assistant)?",
    "context": "Indicates the professional designation of the prescribing physician assistant."
  },
  "T48": {
    "name": "T48",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the prescriber's street address?",
    "context": "Prescriber's primary office address for contact and verification."
  },
  "T49": {
    "name": "T49",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the prescriber's city?",
    "context": "Prescriber's office city for contact and verification."
  },
  "T50": {
    "name": "T50",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the prescriber's state?",
    "context": "Prescriber's office state for contact and verification."
  },
  "T51": {
    "name": "T51",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the prescriber's ZIP code?",
    "context": "Prescriber's office ZIP code for contact and verification."
  },
  "T52": {
    "name": "T52",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the prescriber's phone number?",
    "context": "Prescriber's office phone number for direct contact."
  },
  "T53": {
    "name": "T53",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the prescriber's fax number?",
    "context": "Prescriber's office fax number for sending documents."
  },
  "T54": {
    "name": "T54",
    "type": "text",
    "page": 2,
    "field_label": "St Lic #:",
    "question": "What is the prescriber's state license number?",
    "context": "Prescriber's professional license identifier, mandatory for verification."
  },
  "T55": {
    "name": "T55",
    "type": "text",
    "page": 2,
    "field_label": "NPI #:",
    "question": "What is the prescriber's NPI (National Provider Identifier) number?",
    "context": "Unique identification number for healthcare providers required for billing."
  },
  "T56": {
    "name": "T56",
    "type": "text",
    "page": 2,
    "field_label": "DEA #:",
    "question": "What is the prescriber's DEA (Drug Enforcement Administration) number?",
    "context": "Registration number for prescribers authorized to prescribe controlled substances."
  },
  "T57": {
    "name": "T57",
    "type": "text",
    "page": 2,
    "field_label": "UPIN:",
    "question": "What is the prescriber's UPIN (Unique Physician Identification Number)?",
    "context": "Legacy identifier for physicians previously used by Medicare, may still be requested."
  },
  "T58.0": {
    "name": "T58.0",
    "type": "text",
    "page": 2,
    "field_label": "Provider Email:",
    "question": "What is the prescriber's email address?",
    "context": "Electronic contact information for the prescriber for communication."
  },
  "T58.1": {
    "name": "T58.1",
    "type": "text",
    "page": 2,
    "field_label": "Office Contact Name:",
    "question": "What is the office contact person's name?",
    "context": "Name of an alternative contact person within the prescriber's office."
  },
  "T59": {
    "name": "T59",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the office contact person's phone number?",
    "context": "Phone number for the alternative office contact person."
  },
  "Provider Admin CB.1": {
    "name": "Provider Admin CB.1",
    "type": "checkbox",
    "page": 2,
    "field_label": "Self-administered",
    "question": "Will the medication be self-administered?",
    "context": "Indicates if the patient will administer the medication themselves, impacting dispensing method."
  },
  "Provider Admin CB.2": {
    "name": "Provider Admin CB.2",
    "type": "checkbox",
    "page": 2,
    "field_label": "Physician’s Office",
    "question": "Will the medication be administered in a physician’s office?",
    "context": "Indicates the specific healthcare setting for medication administration."
  },
  "Provider Admin CB.3": {
    "name": "Provider Admin CB.3",
    "type": "checkbox",
    "page": 2,
    "field_label": "Home",
    "question": "Will the medication be administered at home?",
    "context": "Indicates the specific healthcare setting for medication administration."
  },
  "Provider Admin CB.4": {
    "name": "Provider Admin CB.4",
    "type": "checkbox",
    "page": 2,
    "field_label": "Outpatient Infusion Center",
    "question": "Will the medication be administered at an outpatient infusion center?",
    "context": "Indicates the specific healthcare setting for medication administration."
  },
  "Provider Admin T.5": {
    "name": "Provider Admin T.5",
    "type": "text",
    "page": 2,
    "field_label": "Name:",
    "question": "What is the name of the outpatient infusion center?",
    "context": "Required if Outpatient Infusion Center is selected, specifies the facility name."
  },
  "Provider Admin CB.7": {
    "name": "Provider Admin CB.7",
    "type": "checkbox",
    "page": 2,
    "field_label": "Home Infusion Center",
    "question": "Will the medication be administered by a home infusion center?",
    "context": "Indicates if a specialized home infusion service will provide and administer the drug."
  },
  "Provider Admin T.6": {
    "name": "Provider Admin T.6",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number for the home infusion center?",
    "context": "Contact number for the home infusion center providing medication and administration services."
  },
  "Provider Admin T.8": {
    "name": "Provider Admin T.8",
    "type": "text",
    "page": 2,
    "field_label": "Agency Name:",
    "question": "What is the name of the home infusion agency?",
    "context": "Name of the agency providing home infusion services for medication administration."
  },
  "Provider Admin CB.10": {
    "name": "Provider Admin CB.10",
    "type": "checkbox",
    "page": 2,
    "field_label": "Administration code(s)",
    "question": "Are administration codes being provided?",
    "context": "Indicates whether CPT codes for medication administration services will be listed."
  },
  "Provider Admin T.9": {
    "name": "Provider Admin T.9",
    "type": "text",
    "page": 2,
    "field_label": "CPT:",
    "question": "What are the CPT administration codes?",
    "context": "Specific CPT codes used for billing medication administration services, if applicable."
  },
  "Provider Admin T.11A": {
    "name": "Provider Admin T.11A",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the administration address?",
    "context": "Street address of the location where the medication will be administered."
  },
  "Provider Admin T.13": {
    "name": "Provider Admin T.13",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city of administration?",
    "context": "City of the location where the medication will be administered."
  },
  "Provider Admin T.14": {
    "name": "Provider Admin T.14",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state of administration?",
    "context": "State of the location where the medication will be administered."
  },
  "Provider Admin T.15": {
    "name": "Provider Admin T.15",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code of administration?",
    "context": "ZIP code of the location where the medication will be administered."
  },
  "Provider Admin T.16": {
    "name": "Provider Admin T.16",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number of the administration site?",
    "context": "Contact phone number for the location where the medication will be administered."
  },
  "Provider Admin T.17A": {
    "name": "Provider Admin T.17A",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number of the administration site?",
    "context": "Contact fax number for the location where the medication will be administered."
  },
  "Provider Admin T.18": {
    "name": "Provider Admin T.18",
    "type": "text",
    "page": 2,
    "field_label": "TIN:",
    "question": "What is the Tax Identification Number (TIN) of the administration site?",
    "context": "Taxpayer identification for the entity administering the medication, used for billing."
  },
  "Provider Admin T.19": {
    "name": "Provider Admin T.19",
    "type": "text",
    "page": 2,
    "field_label": "PIN:",
    "question": "What is the Provider Identification Number (PIN) of the administration site?",
    "context": "Specific provider identifier for the entity administering the medication."
  },
  "Provider Admin T.20": {
    "name": "Provider Admin T.20",
    "type": "text",
    "page": 2,
    "field_label": "NPI:",
    "question": "What is the NPI (National Provider Identifier) of the administration site?",
    "context": "Unique national identifier for the healthcare provider administering the medication."
  },
  "Provider Admin CB.21": {
    "name": "Provider Admin CB.21",
    "type": "checkbox",
    "page": 2,
    "field_label": "Outpatient Dialysis Center",
    "question": "Will the medication be dispensed/administered at an Outpatient Dialysis Center?",
    "context": "Indicates the specific healthcare setting for medication dispensing or administration."
  },
  "Provider Admin CB.22": {
    "name": "Provider Admin CB.22",
    "type": "checkbox",
    "page": 2,
    "field_label": "Physician’s Office",
    "question": "Will the medication be dispensed/administered at a Physician’s Office?",
    "context": "Indicates the specific healthcare setting for medication dispensing or administration."
  },
  "Provider Admin CB.23.0.0": {
    "name": "Provider Admin CB.23.0.0",
    "type": "checkbox",
    "page": 2,
    "field_label": "Retail Pharmacy",
    "question": "Will the medication be dispensed/administered at a Retail Pharmacy?",
    "context": "Indicates the specific dispensing location for the medication."
  },
  "Provider Admin CB.24.0.0": {
    "name": "Provider Admin CB.24.0.0",
    "type": "checkbox",
    "page": 2,
    "field_label": "Specialty Pharmacy",
    "question": "Will the medication be dispensed/administered at a Specialty Pharmacy?",
    "context": "Indicates the specific dispensing location for complex or high-cost medications."
  },
  "Provider Admin CB.25": {
    "name": "Provider Admin CB.25",
    "type": "checkbox",
    "page": 2,
    "field_label": "Mail Order",
    "question": "Will the medication be dispensed/administered via Mail Order?",
    "context": "Indicates the method of medication dispensing, typically for maintenance drugs."
  },
  "Provider Admin CB.26": {
    "name": "Provider Admin CB.26",
    "type": "checkbox",
    "page": 2,
    "field_label": "Other:",
    "question": "Will the medication be dispensed/administered at an 'Other' location?",
    "context": "Allows for specification of a dispensing/administration location not listed above."
  },
  "Provider Admin T.27": {
    "name": "Provider Admin T.27",
    "type": "text",
    "page": 2,
    "field_label": "Other:",
    "question": "Please specify the 'Other' dispensing/administration location.",
    "context": "Detailed explanation required if the 'Other' dispensing/administration option is selected."
  },
  "Provider Admin T.28": {
    "name": "Provider Admin T.28",
    "type": "text",
    "page": 2,
    "field_label": "Name:",
    "question": "What is the name of the dispensing provider/pharmacy?",
    "context": "Name of the entity responsible for dispensing the requested medication."
  },
  "Provider Admin T.29a": {
    "name": "Provider Admin T.29a",
    "type": "text",
    "page": 2,
    "field_label": "Address:",
    "question": "What is the address of the dispensing provider/pharmacy?",
    "context": "Street address of the entity responsible for dispensing the medication."
  },
  "Provider Admin T.30a": {
    "name": "Provider Admin T.30a",
    "type": "text",
    "page": 2,
    "field_label": "City:",
    "question": "What is the city of the dispensing provider/pharmacy?",
    "context": "City of the entity responsible for dispensing the medication."
  },
  "Provider Admin T.31": {
    "name": "Provider Admin T.31",
    "type": "text",
    "page": 2,
    "field_label": "State:",
    "question": "What is the state of the dispensing provider/pharmacy?",
    "context": "State of the entity responsible for dispensing the medication."
  },
  "Provider Admin T.32": {
    "name": "Provider Admin T.32",
    "type": "text",
    "page": 2,
    "field_label": "ZIP:",
    "question": "What is the ZIP code of the dispensing provider/pharmacy?",
    "context": "ZIP code of the entity responsible for dispensing the medication."
  },
  "Provider Admin T.33": {
    "name": "Provider Admin T.33",
    "type": "text",
    "page": 2,
    "field_label": "Phone:",
    "question": "What is the phone number of the dispensing provider/pharmacy?",
    "context": "Contact phone number for the entity dispensing the medication."
  },
  "Provider Admin T.34": {
    "name": "Provider Admin T.34",
    "type": "text",
    "page": 2,
    "field_label": "Fax:",
    "question": "What is the fax number of the dispensing provider/pharmacy?",
    "context": "Contact fax number for the entity dispensing the medication."
  },
  "Provider Admin T.35": {
    "name": "Provider Admin T.35",
    "type": "text",
    "page": 2,
    "field_label": "TIN:",
    "question": "What is the Tax Identification Number (TIN) of the dispensing provider/pharmacy?",
    "context": "Taxpayer identification for the entity dispensing the medication, used for billing."
  },
  "Provider Admin T.36": {
    "name": "Provider Admin T.36",
    "type": "text",
    "page": 2,
    "field_label": "PIN:",
    "question": "What is the Provider Identification Number (PIN) of the dispensing provider/pharmacy?",
    "context": "Specific provider identifier for the entity dispensing the medication."
  },
  "Provider Admin T.37": {
    "name": "Provider Admin T.37",
    "type": "text",
    "page": 2,
    "field_label": "NPI:",
    "question": "What is the NPI (National Provider Identifier) of the dispensing provider/pharmacy?",
    "context": "Unique national identifier for the healthcare provider dispensing the medication."
  },
  "CB60": {
    "name": "CB60",
    "type": "checkbox",
    "page": 2,
    "field_label": "Riabni (rituximab-arrx)",
    "question": "Is Riabni (rituximab-arrx) the requested product?",
    "context": "Selection of the specific rituximab biosimilar product requested for prior authorization."
  },
  "CB61": {
    "name": "CB61",
    "type": "checkbox",
    "page": 2,
    "field_label": "Rituxan (rituximab)",
    "question": "Is Rituxan (rituximab) the requested product?",
    "context": "Selection of the original rituximab product requested for prior authorization."
  },
  "CB62": {
    "name": "CB62",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Is Ruxience (rituximab-pvvr) the requested product?",
    "context": "Selection of a specific rituximab biosimilar product requested for prior authorization."
  },
  "CB63": {
    "name": "CB63",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Is Truxima (rituximab-abbs) the requested product?",
    "context": "Selection of a specific rituximab biosimilar product requested for prior authorization."
  },
  "T64": {
    "name": "T64",
    "type": "text",
    "page": 2,
    "field_label": "Dose:",
    "question": "What is the prescribed dose of the requested medication?",
    "context": "Details of the medication dosage, crucial for treatment plan review and approval."
  },
  "T65": {
    "name": "T65",
    "type": "text",
    "page": 2,
    "field_label": "Directions for Use:",
    "question": "What are the directions for using the medication?",
    "context": "Instructions for medication administration, including frequency and route."
  },
  "T66": {
    "name": "T66",
    "type": "text",
    "page": 2,
    "field_label": "HCPCS Code:",
    "question": "What is the HCPCS code for the requested product/service?",
    "context": "Healthcare Common Procedure Coding System code for billing the specific medication or service."
  },
  "T67": {
    "name": "T67",
    "type": "text",
    "page": 2,
    "field_label": "Primary ICD Code:",
    "question": "What is the primary ICD code for the patient's diagnosis?",
    "context": "Primary International Classification of Diseases code supporting the medical necessity of the request."
  },
  "CB68": {
    "name": "CB68",
    "type": "checkbox",
    "page": 2,
    "field_label": "Other ICD Code:",
    "question": "Are there any other relevant ICD codes?",
    "context": "Indicates if additional International Classification of Diseases codes are applicable to the patient's diagnosis."
  },
  "T69": {
    "name": "T69",
    "type": "text",
    "page": 2,
    "field_label": "Other ICD Code:",
    "question": "What are the other applicable ICD codes?",
    "context": "Additional International Classification of Diseases codes providing further diagnostic context."
  },
  "CB70": {
    "name": "CB70",
    "type": "checkbox",
    "page": 2,
    "field_label": "Yes",
    "question": "Has the patient had prior therapy with the requested product within the last 365 days?",
    "context": "Determines if the patient has previously used the requested drug within a year, impacting approval."
  },
  "CB71": {
    "name": "CB71",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient not had prior therapy with the requested product within the last 365 days?",
    "context": "Indicates no prior use of the requested drug within a year, relevant for initial approval criteria."
  },
  "CB72": {
    "name": "CB72",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any rituximab biosimilars?",
    "context": "Indicates whether the patient has attempted and failed preferred biosimilar treatments."
  },
  "CB73": {
    "name": "CB73",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Was Ruxience (rituximab-pvvr) tried and failed?",
    "context": "Specific inquiry about the trial and failure of the preferred biosimilar Ruxience."
  },
  "CB74": {
    "name": "CB74",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Was Truxima (rituximab-abbs) tried and failed?",
    "context": "Specific inquiry about the trial and failure of the preferred biosimilar Truxima."
  },
  "T75": {
    "name": "T75",
    "type": "text",
    "page": 2,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient's trial and failure of the preferred drug occur?",
    "context": "Date of the clinical trial and documented failure of the previously preferred medication."
  },
  "T76": {
    "name": "T76",
    "type": "text",
    "page": 2,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Please describe how the preferred drug failed.",
    "context": "Detailed explanation of why the patient's prior therapy with the preferred drug was unsuccessful."
  },
  "CB77": {
    "name": "CB77",
    "type": "checkbox",
    "page": 2,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any rituximab biosimilars?",
    "context": "Indicates whether the patient has experienced adverse reactions to preferred biosimilar treatments."
  },
  "CB78": {
    "name": "CB78",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Did the patient have an adverse reaction to Ruxience (rituximab-pvvr)?",
    "context": "Specific inquiry about adverse reaction to the preferred biosimilar Ruxience."
  },
  "CB79": {
    "name": "CB79",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Did the patient have an adverse reaction to Truxima (rituximab-abbs)?",
    "context": "Specific inquiry about adverse reaction to the preferred biosimilar Truxima."
  },
  "T80": {
    "name": "T80",
    "type": "text",
    "page": 2,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient's adverse reaction to the preferred drug occur?",
    "context": "Date of the patient's documented adverse reaction to the previously preferred medication."
  },
  "T81": {
    "name": "T81",
    "type": "text",
    "page": 2,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Please describe the nature of the patient's adverse reaction to the preferred drug.",
    "context": "Detailed explanation of the type and severity of the adverse reaction experienced by the patient."
  },
  "T84": {
    "name": "T84",
    "type": "text",
    "page": 2,
    "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?",
    "question": "Are there any contraindications or medical reasons preventing the patient from using preferred rituximab biosimilars?",
    "context": "Requires detailed justification if preferred biosimilars are not being used due to medical reasons."
  },
  "CB82": {
    "name": "CB82",
    "type": "checkbox",
    "page": 2,
    "field_label": "Ruxience (rituximab-pvvr)",
    "question": "Is Ruxience (rituximab-pvvr) contraindicated for the patient?",
    "context": "Indicates if Ruxience, a preferred biosimilar, is medically unsuitable due to contraindications."
  },
  "CB83": {
    "name": "CB83",
    "type": "checkbox",
    "page": 2,
    "field_label": "Truxima (rituximab-abbs)",
    "question": "Is Truxima (rituximab-abbs) contraindicated for the patient?",
    "context": "Indicates if Truxima, a preferred biosimilar, is medically unsuitable due to contraindications."
  },
  "CB86": {
    "name": "CB86",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Has the patient had a trial and failure of Inflectra (infliximab-dyyb)?",
    "context": "Clinical information for initiation, indicating prior therapy with a non-preferred infliximab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB87": {
    "name": "CB87",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Has the patient had a trial and failure of Renflexis (infliximab-abda)?",
    "context": "Clinical information for initiation, indicating prior therapy with a non-preferred infliximab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB88": {
    "name": "CB88",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Has the patient had a trial and failure of Simponi Aria (golimumab)?",
    "context": "Clinical information for initiation, indicating prior therapy with a non-preferred golimumab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "T89": {
    "name": "T89",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient's trial and failure of the listed preferred drug occur?",
    "context": "Date of patient's prior therapy failure for a specific preferred drug, required for clinical justification.",
    "value": ""
  },
  "T90": {
    "name": "T90",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Please describe the nature of the patient's failure of the preferred drug.",
    "context": "Detailed explanation of why the patient's prior therapy with the preferred drug was unsuccessful.",
    "value": ""
  },
  "CB85": {
    "name": "CB85",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any of the listed infliximab or golimumab biosimilars?",
    "context": "Indicates if the patient has not failed any specified non-preferred biosimilars (Inflectra, Renflexis, Simponi Aria).",
    "value": "Off"
  },
  "CB92": {
    "name": "CB92",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Has the patient had an adverse reaction to Inflectra (infliximab-dyyb)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a non-preferred infliximab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB93": {
    "name": "CB93",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Has the patient had an adverse reaction to Renflexis (infliximab-abda)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a non-preferred infliximab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB94": {
    "name": "CB94",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Has the patient had an adverse reaction to Simponi Aria (golimumab)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a non-preferred golimumab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "T95": {
    "name": "T95",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient's adverse reaction to the listed preferred drug occur?",
    "context": "Date of patient's adverse reaction to a specific preferred drug, required for clinical justification.",
    "value": ""
  },
  "T96a": {
    "name": "T96a",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Please describe the nature of the patient's adverse reaction to the preferred drug.",
    "context": "Detailed explanation of the adverse reaction experienced by the patient to the preferred drug.",
    "value": ""
  },
  "CB91": {
    "name": "CB91",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any of the listed infliximab or golimumab biosimilars?",
    "context": "Indicates if the patient has not experienced an adverse reaction to specified non-preferred biosimilars.",
    "value": "Off"
  },
  "CB98a": {
    "name": "CB98a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Has the patient had a trial and failure of Enbrel (etanercept)?",
    "context": "Clinical information for initiation, indicating prior therapy with a preferred etanercept product. Part of a sub-question.",
    "value": "Off"
  },
  "CB99a": {
    "name": "CB99a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Has the patient had a trial and failure of Humira (adalimumab)?",
    "context": "Clinical information for initiation, indicating prior therapy with a preferred adalimumab product. Part of a sub-question.",
    "value": "Off"
  },
  "CB100a": {
    "name": "CB100a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Has the patient had a trial and failure of Idacio (adalimumab-aacf)?",
    "context": "Clinical information for initiation, indicating prior therapy with a preferred adalimumab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB101a": {
    "name": "CB101a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Has the patient had a trial and failure of Rinvoq (upadacitinib)?",
    "context": "Clinical information for initiation, indicating prior therapy with a preferred upadacitinib product. Part of a sub-question.",
    "value": "Off"
  },
  "CB102a": {
    "name": "CB102a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Has the patient had a trial and failure of Tyenne SC (tocilizumab-aazg)?",
    "context": "Clinical information for initiation, indicating prior therapy with a preferred tocilizumab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB103a": {
    "name": "CB103a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Has the patient had a trial and failure of Xeljanz/Xeljanz XR (tofacitinib)?",
    "context": "Clinical information for initiation, indicating prior therapy with a preferred tofacitinib product. Part of a sub-question.",
    "value": "Off"
  },
  "T104": {
    "name": "T104",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s trial and failure of the preferred drug?",
    "question": "When did the patient's trial and failure of the listed preferred drug occur?",
    "context": "Date of patient's prior therapy failure for a specific preferred drug, required for clinical justification.",
    "value": ""
  },
  "T105": {
    "name": "T105",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the failure of the preferred drug",
    "question": "Please describe the nature of the patient's failure of the preferred drug.",
    "context": "Detailed explanation of why the patient's prior therapy with the preferred drug was unsuccessful.",
    "value": ""
  },
  "CB97": {
    "name": "CB97",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had a trial and failure of any of the listed preferred drugs?",
    "context": "Indicates if the patient has not failed any specified preferred drugs (Enbrel, Humira, Idacio, Rinvoq, Tyenne, Xeljanz).",
    "value": ""
  },
  "CB107z": {
    "name": "CB107z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Has the patient had an adverse reaction to Enbrel (etanercept)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a preferred etanercept product. Part of a sub-question.",
    "value": "Off"
  },
  "CB108z": {
    "name": "CB108z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Has the patient had an adverse reaction to Humira (adalimumab)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a preferred adalimumab product. Part of a sub-question.",
    "value": "Off"
  },
  "CB109z": {
    "name": "CB109z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Has the patient had an adverse reaction to Idacio (adalimumab-aacf)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a preferred adalimumab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB110z": {
    "name": "CB110z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Has the patient had an adverse reaction to Rinvoq (upadacitinib)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a preferred upadacitinib product. Part of a sub-question.",
    "value": "Off"
  },
  "CB111z": {
    "name": "CB111z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Has the patient had an adverse reaction to Tyenne SC (tocilizumab-aazg)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a preferred tocilizumab biosimilar. Part of a sub-question.",
    "value": "Off"
  },
  "CB112z": {
    "name": "CB112z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Has the patient had an adverse reaction to Xeljanz/Xeljanz XR (tofacitinib)?",
    "context": "Clinical information for initiation, indicating an adverse reaction to a preferred tofacitinib product. Part of a sub-question.",
    "value": "Off"
  },
  "T113": {
    "name": "T113",
    "type": "text",
    "page": 3,
    "field_label": "When was the member’s adverse reaction to the preferred drug?",
    "question": "When did the patient's adverse reaction to the listed preferred drug occur?",
    "context": "Date of patient's adverse reaction to a specific preferred drug, required for clinical justification.",
    "value": ""
  },
  "T114": {
    "name": "T114",
    "type": "text",
    "page": 3,
    "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
    "question": "Please describe the nature of the patient's adverse reaction to the preferred drug.",
    "context": "Detailed explanation of the adverse reaction experienced by the patient to the preferred drug.",
    "value": ""
  },
  "CB106z": {
    "name": "CB106z",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Has the patient NOT had an adverse reaction to any of the listed preferred drugs?",
    "context": "Indicates if the patient has not experienced an adverse reaction to specified preferred drugs (Enbrel, Humira, Idacio, Rinvoq, Tyenne, Xeljanz).",
    "value": "Off"
  },
  "T118": {
    "name": "T118",
    "type": "text",
    "page": 3,
    "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
    "question": "Are there contraindications or medical reasons preventing the patient from using the listed preferred products for their diagnosis?",
    "context": "Open-text explanation of clinical reasons or contraindications for not using specified preferred biosimilars (Inflectra, Renflexis, Simponi Aria).",
    "value": ""
  },
  "CB115z": {
    "name": "CB115z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Inflectra (infliximab-dyyb)",
    "question": "Is Inflectra (infliximab-dyyb) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred biosimilar if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB116z": {
    "name": "CB116z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Renflexis (infliximab-abda)",
    "question": "Is Renflexis (infliximab-abda) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred biosimilar if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB117z": {
    "name": "CB117z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Simponi Aria (golimumab)",
    "question": "Is Simponi Aria (golimumab) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred biosimilar if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "T125": {
    "name": "T125",
    "type": "text",
    "page": 3,
    "field_label": "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
    "question": "Are there contraindications or medical reasons preventing the patient from using the listed preferred products for their diagnosis?",
    "context": "Open-text explanation of clinical reasons or contraindications for not using specified preferred drugs.",
    "value": ""
  },
  "CB119z": {
    "name": "CB119z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Enbrel (etanercept)",
    "question": "Is Enbrel (etanercept) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred drug if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB120z": {
    "name": "CB120z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Humira (adalimumab)",
    "question": "Is Humira (adalimumab) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred drug if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB121z": {
    "name": "CB121z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Idacio (adalimumab-aacf)",
    "question": "Is Idacio (adalimumab-aacf) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred drug if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB122z": {
    "name": "CB122z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Rinvoq (upadacitinib)",
    "question": "Is Rinvoq (upadacitinib) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred drug if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB123z": {
    "name": "CB123z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Tyenne SC (tocilizumab-aazg)",
    "question": "Is Tyenne SC (tocilizumab-aazg) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred drug if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB124z": {
    "name": "CB124z",
    "type": "checkbox",
    "page": 3,
    "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
    "question": "Is Xeljanz/Xeljanz XR (tofacitinib) contraindicated or medically unsuitable for the patient?",
    "context": "Option to select a specific preferred drug if contraindicated or medically unsuitable for the patient's diagnosis.",
    "value": "Off"
  },
  "CB96.4.0": {
    "name": "CB96.4.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
    "context": "Indicates whether Rituxan will be co-administered with other biologic or small molecule DMARDs, important for treatment plan.",
    "value": "Off"
  },
  "CB98": {
    "name": "CB98",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) NOT be used concomitantly with apremilast, tofacitinib, or other biologic DMARDs?",
    "context": "Indicates whether Rituxan will NOT be co-administered with other biologic or small molecule DMARDs, important for treatment plan.",
    "value": ""
  },
  "CB99.0": {
    "name": "CB99.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
    "context": "Confirms specific diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia, relevant for Rituxan approval.",
    "value": "Off"
  },
  "CB100.0": {
    "name": "CB100.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
    "context": "Indicates absence of Philadelphia chromosome-negative acute lymphoid leukemia, relevant for Rituxan approval.",
    "value": "Off"
  },
  "CB101.0": {
    "name": "CB101.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as induction/consolidation therapy?",
    "context": "Confirms the treatment phase (induction/consolidation) for Rituxan use in acute lymphoid leukemia.",
    "value": "Off"
  },
  "CB102.0": {
    "name": "CB102.0",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) NOT being used as induction/consolidation therapy?",
    "context": "Indicates Rituxan's use is not for induction/consolidation phase in acute lymphoid leukemia.",
    "value": "Off"
  },
  "CB103": {
    "name": "CB103",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
    "context": "Confirms specific diagnosis of refractory autoimmune hemolytic anemia, relevant for Rituxan approval.",
    "value": "Off"
  },
  "CB104": {
    "name": "CB104",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of refractory autoimmune hemolytic anemia?",
    "context": "Indicates absence of refractory autoimmune hemolytic anemia, relevant for Rituxan approval.",
    "value": "Off"
  },
  "CB104a": {
    "name": "CB104a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Wegener granulomatosis",
    "question": "Does the patient have Wegener granulomatosis?",
    "context": "Specific ANCA-associated vasculitides diagnosis, relevant for Rituxan approval in anti-neutrophil cytoplasmic antibody-associated vasculitides.",
    "value": "Off"
  },
  "CB104b": {
    "name": "CB104b",
    "type": "checkbox",
    "page": 3,
    "field_label": "Churg-Strauss syndrome",
    "question": "Does the patient have Churg-Strauss syndrome?",
    "context": "Specific ANCA-associated vasculitides diagnosis, relevant for Rituxan approval in anti-neutrophil cytoplasmic antibody-associated vasculitides.",
    "value": "Off"
  },
  "CB104c": {
    "name": "CB104c",
    "type": "checkbox",
    "page": 3,
    "field_label": "microscopic polyangiitis",
    "question": "Does the patient have microscopic polyangiitis?",
    "context": "Specific ANCA-associated vasculitides diagnosis, relevant for Rituxan approval in anti-neutrophil cytoplasmic antibody-associated vasculitides.",
    "value": "Off"
  },
  "CB104d": {
    "name": "CB104d",
    "type": "checkbox",
    "page": 3,
    "field_label": "pauci-immune glomerulonephritis",
    "question": "Does the patient have pauci-immune glomerulonephritis?",
    "context": "Specific ANCA-associated vasculitides diagnosis, relevant for Rituxan approval in anti-neutrophil cytoplasmic antibody-associated vasculitides.",
    "value": "Off"
  },
  "CB105": {
    "name": "CB105",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
    "context": "Confirms co-administration of Rituxan with glucocorticoids for ANCA-associated vasculitides treatment.",
    "value": "Off"
  },
  "CB106": {
    "name": "CB106",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) NOT be given in conjunction with glucocorticoids?",
    "context": "Indicates no co-administration of Rituxan with glucocorticoids for ANCA-associated vasculitides treatment.",
    "value": ""
  },
  "CB106a": {
    "name": "CB106a",
    "type": "checkbox",
    "page": 3,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
    "context": "Confirms specific diagnosis of corticosteroid-refractory autoimmune blistering disease, relevant for Rituxan approval.",
    "value": ""
  },
  "CB107": {
    "name": "CB107",
    "type": "checkbox",
    "page": 3,
    "field_label": "pemphigus vulgaris",
    "question": "Does the patient have pemphigus vulgaris?",
    "context": "Specific autoimmune blistering disease diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB108": {
    "name": "CB108",
    "type": "checkbox",
    "page": 3,
    "field_label": "pemphigus folliaceus",
    "question": "Does the patient have pemphigus folliaceus?",
    "context": "Specific autoimmune blistering disease diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB109": {
    "name": "CB109",
    "type": "checkbox",
    "page": 3,
    "field_label": "bullous pemphigoid",
    "question": "Does the patient have bullous pemphigoid?",
    "context": "Specific autoimmune blistering disease diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB110": {
    "name": "CB110",
    "type": "checkbox",
    "page": 3,
    "field_label": "cicatricial pemphigoid",
    "question": "Does the patient have cicatricial pemphigoid?",
    "context": "Specific autoimmune blistering disease diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB111": {
    "name": "CB111",
    "type": "checkbox",
    "page": 3,
    "field_label": "epidermolysis bullosa acquisita",
    "question": "Does the patient have epidermolysis bullosa acquisita?",
    "context": "Specific autoimmune blistering disease diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB112": {
    "name": "CB112",
    "type": "checkbox",
    "page": 3,
    "field_label": "paraneoplastic pemphigus",
    "question": "Does the patient have paraneoplastic pemphigus?",
    "context": "Specific autoimmune blistering disease diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB113": {
    "name": "CB113",
    "type": "checkbox",
    "page": 3,
    "field_label": "None of the above",
    "question": "Does the patient have none of the listed autoimmune blistering diseases?",
    "context": "Indicates that the patient's autoimmune blistering disease is not among the specific options provided.",
    "value": "Off"
  },
  "CB106b": {
    "name": "CB106b",
    "type": "checkbox",
    "page": 3,
    "field_label": "No",
    "question": "Does the patient NOT have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
    "context": "Indicates absence of corticosteroid-refractory autoimmune blistering disease, relevant for Rituxan approval.",
    "value": ""
  },
  "CB114": {
    "name": "CB114",
    "type": "checkbox",
    "page": 3,
    "field_label": "AIDS-related B-cell lymphoma",
    "question": "Does the patient have AIDS-related B-cell lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": "Off"
  },
  "CB115": {
    "name": "CB115",
    "type": "checkbox",
    "page": 3,
    "field_label": "Burkitt lymphoma",
    "question": "Does the patient have Burkitt lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB116": {
    "name": "CB116",
    "type": "checkbox",
    "page": 3,
    "field_label": "Diffuse large B-cell lymphoma",
    "question": "Does the patient have Diffuse large B-cell lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB117": {
    "name": "CB117",
    "type": "checkbox",
    "page": 3,
    "field_label": "Follicular lymphoma",
    "question": "Does the patient have Follicular lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB118": {
    "name": "CB118",
    "type": "checkbox",
    "page": 3,
    "field_label": "Gastric MALT lymphoma",
    "question": "Does the patient have Gastric MALT lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": "Off"
  },
  "CB119": {
    "name": "CB119",
    "type": "checkbox",
    "page": 3,
    "field_label": "High-grade B-Cell lymphoma",
    "question": "Does the patient have High-grade B-Cell lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB120": {
    "name": "CB120",
    "type": "checkbox",
    "page": 3,
    "field_label": "Mantle cell lymphoma",
    "question": "Does the patient have Mantle cell lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB121": {
    "name": "CB121",
    "type": "checkbox",
    "page": 3,
    "field_label": "Nodal marginal zone lymphoma",
    "question": "Does the patient have Nodal marginal zone lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB122": {
    "name": "CB122",
    "type": "checkbox",
    "page": 3,
    "field_label": "Nongastric MALT lymphoma",
    "question": "Does the patient have Nongastric MALT lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB123": {
    "name": "CB123",
    "type": "checkbox",
    "page": 3,
    "field_label": "Primary cutaneous B-cell lymphomas",
    "question": "Does the patient have Primary cutaneous B-cell lymphomas?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB124": {
    "name": "CB124",
    "type": "checkbox",
    "page": 3,
    "field_label": "Splenic marginal zone lymphoma",
    "question": "Does the patient have Splenic marginal zone lymphoma?",
    "context": "Specific B-cell lymphoma diagnosis, relevant for Rituxan approval.",
    "value": ""
  },
  "CB125": {
    "name": "CB125",
    "type": "checkbox",
    "page": 3,
    "field_label": "Other:",
    "question": "Does the patient have an 'Other' unspecified B-cell lymphoma?",
    "context": "Option to indicate B-cell lymphoma type not listed, requires further specification in the text field.",
    "value": "Off"
  },
  "T126": {
    "name": "T126",
    "type": "text",
    "page": 3,
    "field_label": "Other:",
    "question": "Please specify the 'Other' B-cell lymphoma type.",
    "context": "Open-text field to describe the specific 'Other' B-cell lymphoma diagnosis not listed above.",
    "value": ""
  },
  "CB127": {
    "name": "CB127",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of multicentric Castleman's disease (angiofollicular lymph node hyperplasia)?",
    "context": "Confirms the primary diagnosis of multicentric Castleman's disease for treatment approval."
  },
  "CB128": {
    "name": "CB128",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of multicentric Castleman's disease (angiofollicular lymph node hyperplasia)?",
    "context": "Indicates absence of multicentric Castleman's disease, influencing treatment eligibility."
  },
  "CB129": {
    "name": "CB129",
    "type": "checkbox",
    "page": 4,
    "field_label": "leptomeningeal metastases from lymphoma",
    "question": "Is the patient's central nervous system lymphoma characterized by leptomeningeal metastases?",
    "context": "Specifies a particular type of central nervous system lymphoma affecting treatment protocol."
  },
  "CB130": {
    "name": "CB130",
    "type": "checkbox",
    "page": 4,
    "field_label": "primary CNS lymphoma",
    "question": "Is the patient's central nervous system lymphoma a primary CNS lymphoma?",
    "context": "Specifies the primary form of central nervous system lymphoma for diagnosis."
  },
  "CB131": {
    "name": "CB131",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Does none of the listed options apply to the patient's central nervous system lymphoma?",
    "context": "Indicates if other or unspecified types of CNS lymphoma are present."
  },
  "CB132": {
    "name": "CB132",
    "type": "checkbox",
    "page": 4,
    "field_label": "chronic lymphocytic leukemia (CLL)",
    "question": "Does the patient have chronic lymphocytic leukemia (CLL)?",
    "context": "Identifies the specific type of chronic leukemia for which treatment is requested."
  },
  "CB133": {
    "name": "CB133",
    "type": "checkbox",
    "page": 4,
    "field_label": "small lymphocytic leukemia",
    "question": "Does the patient have small lymphocytic leukemia?",
    "context": "Identifies the specific type of small lymphocytic leukemia for which treatment is requested."
  },
  "CB134": {
    "name": "CB134",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Does none of the listed options apply to the patient's chronic or small lymphocytic leukemia?",
    "context": "Indicates if other or unspecified types of chronic/small lymphocytic leukemia are present."
  },
  "CB135": {
    "name": "CB135",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of cryoglobulinemia?",
    "context": "Confirms the primary diagnosis of cryoglobulinemia for treatment approval."
  },
  "CB136": {
    "name": "CB136",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of cryoglobulinemia?",
    "context": "Indicates absence of cryoglobulinemia, influencing treatment eligibility."
  },
  "CB139": {
    "name": "CB139",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there clinical documentation that the patient's treatment with corticosteroids and other immunosuppressive agents for cryoglobulinemia was ineffective?",
    "context": "Verifies documented failure of prior therapies for cryoglobulinemia before considering Rituxan."
  },
  "CB140": {
    "name": "CB140",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there no clinical documentation that the patient's treatment with corticosteroids and other immunosuppressive agents for cryoglobulinemia was ineffective?",
    "context": "Indicates prior therapies may still be effective, or lack of documented failure for cryoglobulinemia."
  },
  "CB144": {
    "name": "CB144",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there documentation that Rituxan (rituximab) is being used as a last-resort treatment for chronic graft versus host disease (GVHD)?",
    "context": "Confirms Rituxan's use as a last-resort option for chronic GVHD, supporting medical necessity."
  },
  "CB145": {
    "name": "CB145",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there no documentation that Rituxan (rituximab) is being used as a last-resort treatment for chronic graft versus host disease (GVHD)?",
    "context": "Indicates Rituxan may not be considered last-resort for chronic GVHD, affecting approval."
  },
  "CB141": {
    "name": "CB141",
    "type": "checkbox",
    "page": 4,
    "field_label": "relapsed hairy cell leukemia",
    "question": "Does the patient have relapsed hairy cell leukemia?",
    "context": "Specifies if the patient's hairy cell leukemia has relapsed, influencing treatment strategy."
  },
  "CB142": {
    "name": "CB142",
    "type": "checkbox",
    "page": 4,
    "field_label": "refractory hairy cell leukemia",
    "question": "Does the patient have refractory hairy cell leukemia?",
    "context": "Specifies if the patient's hairy cell leukemia is refractory to prior treatments."
  },
  "CB143": {
    "name": "CB143",
    "type": "checkbox",
    "page": 4,
    "field_label": "none of the above",
    "question": "Does none of the listed options apply to the patient's hairy cell leukemia?",
    "context": "Indicates if other or unspecified types of hairy cell leukemia are present."
  },
  "CB137": {
    "name": "CB137",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is there documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart or other solid organ transplant recipients?",
    "context": "Verifies documented use of Rituxan for desensitization in highly sensitized transplant patients."
  },
  "CB146": {
    "name": "CB146",
    "type": "checkbox",
    "page": 4,
    "field_label": "heart transplant recipient",
    "question": "Is the patient a heart transplant recipient?",
    "context": "Identifies the specific type of organ transplant received by the patient."
  },
  "CB147": {
    "name": "CB147",
    "type": "checkbox",
    "page": 4,
    "field_label": "other solid organ transplant recipient",
    "question": "Is the patient an other solid organ transplant recipient?",
    "context": "Identifies if the patient received a solid organ transplant other than a heart."
  },
  "CB138": {
    "name": "CB138",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is there no documentation that Rituxan (rituximab) is being used for treatment or prevention (desensitization) of highly sensitized patients with antibody mediated rejection in heart or other solid organ transplant recipients?",
    "context": "Indicates absence of documented Rituxan use for desensitization in transplant patients."
  },
  "CB148": {
    "name": "CB148",
    "type": "checkbox",
    "page": 4,
    "field_label": "Bavencio (avelumab)",
    "question": "Was Bavencio (avelumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies if Bavencio was the specific agent causing immune checkpoint inhibitor-related encephalitis."
  },
  "CB149": {
    "name": "CB149",
    "type": "checkbox",
    "page": 4,
    "field_label": "Imfinzi (durvalumab)",
    "question": "Was Imfinzi (durvalumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies if Imfinzi was the specific agent causing immune checkpoint inhibitor-related encephalitis."
  },
  "CB150": {
    "name": "CB150",
    "type": "checkbox",
    "page": 4,
    "field_label": "Keytruda (pembrolizumab)",
    "question": "Was Keytruda (pembrolizumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies if Keytruda was the specific agent causing immune checkpoint inhibitor-related encephalitis."
  },
  "CB151": {
    "name": "CB151",
    "type": "checkbox",
    "page": 4,
    "field_label": "Opdivo (nivolumab)",
    "question": "Was Opdivo (nivolumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies if Opdivo was the specific agent causing immune checkpoint inhibitor-related encephalitis."
  },
  "CB152": {
    "name": "CB152",
    "type": "checkbox",
    "page": 4,
    "field_label": "Tecentriq (atezolizumab)",
    "question": "Was Tecentriq (atezolizumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies if Tecentriq was the specific agent causing immune checkpoint inhibitor-related encephalitis."
  },
  "CB153": {
    "name": "CB153",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yervoy (ipilimumab)",
    "question": "Was Yervoy (ipilimumab) the immune checkpoint inhibitor that caused the encephalitis?",
    "context": "Identifies if Yervoy was the specific agent causing immune checkpoint inhibitor-related encephalitis."
  },
  "CB154": {
    "name": "CB154",
    "type": "checkbox",
    "page": 4,
    "field_label": "Other:",
    "question": "Was an immune checkpoint inhibitor other than those listed the cause of the encephalitis?",
    "context": "Allows for specification of other immune checkpoint inhibitors causing encephalitis."
  },
  "T155": {
    "name": "T155",
    "type": "text",
    "page": 4,
    "field_label": "Other:",
    "question": "Please specify the other immune checkpoint inhibitor that caused the encephalitis.",
    "context": "Text field to specify the name of an unlisted immune checkpoint inhibitor."
  },
  "CB156": {
    "name": "CB156",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Confirms the diagnosis of refractory ITP, a key eligibility criterion for treatment."
  },
  "CB158": {
    "name": "CB158",
    "type": "checkbox",
    "page": 4,
    "field_label": "refractory immune thrombocytopenic purpura",
    "question": "Does the patient have refractory immune thrombocytopenic purpura?",
    "context": "Specifies if the patient's ITP is refractory to previous treatments."
  },
  "CB159": {
    "name": "CB159",
    "type": "checkbox",
    "page": 4,
    "field_label": "idiopathic thrombocytopenic purpura (ITP)",
    "question": "Does the patient have idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Specifies if the patient's ITP is idiopathic in nature."
  },
  "CB157": {
    "name": "CB157",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
    "context": "Indicates absence of documented refractory ITP, affecting treatment eligibility."
  },
  "CB160": {
    "name": "CB160",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
    "context": "Determines if Rituxan is used for rejection prevention in specific kidney transplant cases."
  },
  "CB161": {
    "name": "CB161",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) not being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
    "context": "Indicates Rituxan is not for rejection prevention in specific kidney transplant cases."
  },
  "CB162": {
    "name": "CB162",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
    "context": "Confirms the primary diagnosis of lymphocyte-predominant Hodgkin's lymphoma."
  },
  "CB163": {
    "name": "CB163",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
    "context": "Indicates absence of documented lymphocyte-predominant Hodgkin's lymphoma."
  },
  "CB164": {
    "name": "CB164",
    "type": "checkbox",
    "page": 4,
    "field_label": "Relapsing-remitting MS (RRMS)",
    "question": "Has the patient been diagnosed with Relapsing-remitting Multiple Sclerosis (RRMS)?",
    "context": "Identifies the specific type of Multiple Sclerosis diagnosis for treatment indication."
  },
  "CB165": {
    "name": "CB165",
    "type": "checkbox",
    "page": 4,
    "field_label": "Secondary-progressive MS (SPMS)",
    "question": "Has the patient been diagnosed with Secondary-progressive Multiple Sclerosis (SPMS)?",
    "context": "Identifies the specific type of Multiple Sclerosis diagnosis for treatment indication."
  },
  "CB166": {
    "name": "CB166",
    "type": "checkbox",
    "page": 4,
    "field_label": "Primary-progressive MS (PPMS)",
    "question": "Has the patient been diagnosed with Primary-progressive Multiple Sclerosis (PPMS)?",
    "context": "Identifies the specific type of Multiple Sclerosis diagnosis for treatment indication."
  },
  "CB167": {
    "name": "CB167",
    "type": "checkbox",
    "page": 4,
    "field_label": "Progressive-relapsing MS (PRMS)",
    "question": "Has the patient been diagnosed with Progressive-relapsing Multiple Sclerosis (PRMS)?",
    "context": "Identifies the specific type of Multiple Sclerosis diagnosis for treatment indication."
  },
  "CB168": {
    "name": "CB168",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Has the patient discontinued other medications used for treating MS (not including Ampyra)?",
    "context": "Determines if other MS medications (excluding Ampyra) have been discontinued."
  },
  "CB169": {
    "name": "CB169",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Has the patient not discontinued other medications used for treating MS (not including Ampyra)?",
    "context": "Indicates if other MS medications (excluding Ampyra) are still being used or not discontinued."
  },
  "CB170": {
    "name": "CB170",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
    "context": "Confirms the specific diagnosis of MuSK-MG for treatment consideration."
  },
  "CB172": {
    "name": "CB172",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Has the patient had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
    "context": "Determines if initial immunotherapy for MuSK-MG was unsuccessful, supporting further treatment."
  },
  "CB173": {
    "name": "CB173",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Has the patient not had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
    "context": "Indicates initial immunotherapy for MuSK-MG was satisfactory or not attempted yet."
  },
  "CB171": {
    "name": "CB171",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
    "context": "Indicates absence of documented MuSK-MG diagnosis."
  },
  "CB174": {
    "name": "CB174",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
    "context": "Confirms the diagnosis of neuromyelitis optica for treatment consideration."
  },
  "CB175": {
    "name": "CB175",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
    "context": "Indicates absence of documented neuromyelitis optica diagnosis."
  },
  "CB176": {
    "name": "CB176",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Was the patient's treatment with at least one immunotherapy for neuromyelitis optica ineffective?",
    "context": "Determines if previous immunotherapy for neuromyelitis optica was unsuccessful."
  },
  "CB177": {
    "name": "CB177",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Was the patient's treatment with at least one immunotherapy for neuromyelitis optica not ineffective?",
    "context": "Indicates previous immunotherapy for neuromyelitis optica was effective or not attempted."
  },
  "CB178": {
    "name": "CB178",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
    "context": "Confirms OMA diagnosis linked to neuroblastoma, essential for specific treatment."
  },
  "CB179": {
    "name": "CB179",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
    "context": "Indicates absence of OMA diagnosis associated with neuroblastoma."
  },
  "CB180": {
    "name": "CB180",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is the patient refractory to steroids, chemotherapy, and intravenous immunoglobulins for OMA?",
    "context": "Determines if standard OMA treatments (steroids, chemo, IVIG) have failed, indicating refractoriness."
  },
  "T189": {
    "name": "T189",
    "type": "text",
    "page": 4,
    "field_label": "Medication:",
    "question": "What was the name of the medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Records the name of previously attempted medication for OMA."
  },
  "T190": {
    "name": "T190",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date range for which the medication was tried?",
    "context": "Records the start month of medication trial for OMA."
  },
  "T191": {
    "name": "T191",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date range for which the medication was tried?",
    "context": "Records the start day of medication trial for OMA."
  },
  "T192": {
    "name": "T192",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date range for which the medication was tried?",
    "context": "Records the start year of medication trial for OMA."
  },
  "T193": {
    "name": "T193",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month of the second date range for which the medication was tried?",
    "context": "Records the end month of medication trial for OMA, if applicable."
  },
  "T194": {
    "name": "T194",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day of the second date range for which the medication was tried?",
    "context": "Records the end day of medication trial for OMA, if applicable."
  },
  "T195": {
    "name": "T195",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the second date range for which the medication was tried?",
    "context": "Records the end year of medication trial for OMA, if applicable."
  },
  "T196": {
    "name": "T196",
    "type": "text",
    "page": 4,
    "field_label": "Medication:",
    "question": "What was the name of the second medication tried for opsoclonus-myoclonus-ataxia?",
    "context": "Records the name of another previously attempted medication for OMA."
  },
  "T197": {
    "name": "T197",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date range for which the second medication was tried?",
    "context": "Records the start month of the second medication trial for OMA."
  },
  "T198": {
    "name": "T198",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date range for which the second medication was tried?",
    "context": "Records the start day of the second medication trial for OMA."
  },
  "T199": {
    "name": "T199",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date range for which the second medication was tried?",
    "context": "Records the start year of the second medication trial for OMA."
  },
  "T200": {
    "name": "T200",
    "type": "text",
    "page": 4,
    "field_label": "Date: (MM)",
    "question": "What is the month of the second date range for which the second medication was tried?",
    "context": "Records the end month of the second medication trial for OMA, if applicable."
  },
  "T201": {
    "name": "T201",
    "type": "text",
    "page": 4,
    "field_label": "Date: (DD)",
    "question": "What is the day of the second date range for which the second medication was tried?",
    "context": "Records the end day of the second medication trial for OMA, if applicable."
  },
  "T202": {
    "name": "T202",
    "type": "text",
    "page": 4,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the second date range for which the second medication was tried?",
    "context": "Records the end year of the second medication trial for OMA, if applicable."
  },
  "CB181": {
    "name": "CB181",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is the patient not refractory to steroids, chemotherapy, and intravenous immunoglobulins for OMA?",
    "context": "Indicates standard OMA treatments (steroids, chemo, IVIG) may still be effective."
  },
  "CB203": {
    "name": "CB203",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as treatment for post-transplant lymphoproliferative disorder?",
    "context": "Determines if Rituxan is used to treat post-transplant lymphoproliferative disorder (PTLD)."
  },
  "CB204": {
    "name": "CB204",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) not being used as treatment for post-transplant lymphoproliferative disorder?",
    "context": "Indicates Rituxan is not for PTLD treatment, affecting approval."
  },
  "CB205": {
    "name": "CB205",
    "type": "checkbox",
    "page": 4,
    "field_label": "Yes",
    "question": "Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
    "context": "Determines if Rituxan is used for EBV prophylaxis against PTLD in transplant patients."
  },
  "CB206": {
    "name": "CB206",
    "type": "checkbox",
    "page": 4,
    "field_label": "No",
    "question": "Is Rituxan (rituximab) not being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
    "context": "Indicates Rituxan is not for EBV prophylaxis against PTLD, affecting approval."
  },
  "CB207": {
    "name": "CB207",
    "type": "checkbox",
    "page": 5,
    "field_label": "Mild",
    "question": "Is the patient's rheumatoid arthritis classified as mild?",
    "context": "Clinical assessment of rheumatoid arthritis severity at baseline in the clinical information section."
  },
  "CB208": {
    "name": "CB208",
    "type": "checkbox",
    "page": 5,
    "field_label": "Moderate",
    "question": "Is the patient's rheumatoid arthritis classified as moderate?",
    "context": "Clinical assessment of rheumatoid arthritis severity at baseline in the clinical information section."
  },
  "CB209": {
    "name": "CB209",
    "type": "checkbox",
    "page": 5,
    "field_label": "Severe",
    "question": "Is the patient's rheumatoid arthritis classified as severe?",
    "context": "Clinical assessment of rheumatoid arthritis severity at baseline in the clinical information section."
  },
  "CB210": {
    "name": "CB210",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there evidence that the rheumatoid arthritis disease is active?",
    "context": "Indicates current disease activity for rheumatoid arthritis to justify treatment initiation."
  },
  "CB211": {
    "name": "CB211",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no evidence that the rheumatoid arthritis disease is active?",
    "context": "Indicates lack of current disease activity for rheumatoid arthritis, impacting treatment justification."
  },
  "CB212": {
    "name": "CB212",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Will Rituxan (rituximab) be used in combination with methotrexate?",
    "context": "Treatment plan detail for rheumatoid arthritis, assessing concomitant methotrexate therapy."
  },
  "CB213": {
    "name": "CB213",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Will Rituxan (rituximab) not be used in combination with methotrexate?",
    "context": "Treatment plan detail for rheumatoid arthritis, assessing absence of concomitant methotrexate therapy."
  },
  "CB214": {
    "name": "CB214",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
    "context": "Evaluates prior methotrexate therapy failure, intolerance, or contraindication for rheumatoid arthritis."
  },
  "CB216": {
    "name": "CB216",
    "type": "checkbox",
    "page": 5,
    "field_label": "ineffective",
    "question": "Was methotrexate treatment ineffective?",
    "context": "Specific reason for prior methotrexate failure in rheumatoid arthritis, indicating lack of therapeutic response."
  },
  "CB217": {
    "name": "CB217",
    "type": "checkbox",
    "page": 5,
    "field_label": "not tolerated",
    "question": "Was methotrexate treatment not tolerated?",
    "context": "Specific reason for prior methotrexate failure in rheumatoid arthritis, indicating adverse effects."
  },
  "CB218": {
    "name": "CB218",
    "type": "checkbox",
    "page": 5,
    "field_label": "contraindicated",
    "question": "Was methotrexate treatment contraindicated?",
    "context": "Specific reason for prior methotrexate failure in rheumatoid arthritis, indicating medical unsuitability."
  },
  "CB215": {
    "name": "CB215",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with methotrexate not ineffective, not tolerated, or contraindicated?",
    "context": "Evaluates success, tolerance, or suitability of prior methotrexate therapy for rheumatoid arthritis."
  },
  "CB223": {
    "name": "CB223",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with another conventional DMARD ineffective?",
    "context": "Evaluates prior therapy failure with other conventional DMARDs for rheumatoid arthritis."
  },
  "CB225": {
    "name": "CB225",
    "type": "checkbox",
    "page": 5,
    "field_label": "azathioprine",
    "question": "Was azathioprine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD that failed for rheumatoid arthritis, indicating prior treatment history."
  },
  "CB226": {
    "name": "CB226",
    "type": "checkbox",
    "page": 5,
    "field_label": "cyclosporine",
    "question": "Was cyclosporine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD that failed for rheumatoid arthritis, indicating prior treatment history."
  },
  "CB227": {
    "name": "CB227",
    "type": "checkbox",
    "page": 5,
    "field_label": "hydroxychloroquine",
    "question": "Was hydroxychloroquine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD that failed for rheumatoid arthritis, indicating prior treatment history."
  },
  "CB228": {
    "name": "CB228",
    "type": "checkbox",
    "page": 5,
    "field_label": "leflunomide",
    "question": "Was leflunomide an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD that failed for rheumatoid arthritis, indicating prior treatment history."
  },
  "CB229": {
    "name": "CB229",
    "type": "checkbox",
    "page": 5,
    "field_label": "sulfasalazine",
    "question": "Was sulfasalazine an ineffective conventional DMARD?",
    "context": "Specific conventional DMARD that failed for rheumatoid arthritis, indicating prior treatment history."
  },
  "CB224": {
    "name": "CB224",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with another conventional DMARD not ineffective?",
    "context": "Evaluates success of prior therapy with other conventional DMARDs for rheumatoid arthritis."
  },
  "CB281": {
    "name": "CB281",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Sjögren's syndrome?",
    "context": "Primary diagnostic criterion for Sjögren's syndrome, essential for treatment approval."
  },
  "CB282": {
    "name": "CB282",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of Sjögren's syndrome?",
    "context": "Primary diagnostic criterion for Sjögren's syndrome, impacting treatment approval."
  },
  "CB283": {
    "name": "CB283",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Was treatment with corticosteroids and other immunosuppressive agents ineffective?",
    "context": "Evaluates prior therapy failure with corticosteroids or immunosuppressive agents for Sjögren's syndrome."
  },
  "T285": {
    "name": "T285",
    "type": "text",
    "page": 5,
    "field_label": "Medication:",
    "question": "What is the name of the first corticosteroid or immunosuppressive agent used?",
    "context": "Details of specific prior failed medication for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T286": {
    "name": "T286",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date the first corticosteroid/immunosuppressive agent was used?",
    "context": "Start month of prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T287": {
    "name": "T287",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date the first corticosteroid/immunosuppressive agent was used?",
    "context": "Start day of prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T288": {
    "name": "T288",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date the first corticosteroid/immunosuppressive agent was used?",
    "context": "Start year of prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T289": {
    "name": "T289",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date the second corticosteroid/immunosuppressive agent was used?",
    "context": "Start month of a second prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T290": {
    "name": "T290",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date the second corticosteroid/immunosuppressive agent was used?",
    "context": "Start day of a second prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T291": {
    "name": "T291",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date the second corticosteroid/immunosuppressive agent was used?",
    "context": "Start year of a second prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T292": {
    "name": "T292",
    "type": "text",
    "page": 5,
    "field_label": "Medication:",
    "question": "What is the name of the second corticosteroid or immunosuppressive agent used?",
    "context": "Details of a second specific prior failed medication for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T293": {
    "name": "T293",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date the third corticosteroid/immunosuppressive agent was used?",
    "context": "Start month of a third prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T294": {
    "name": "T294",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date the third corticosteroid/immunosuppressive agent was used?",
    "context": "Start day of a third prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T295": {
    "name": "T295",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date the third corticosteroid/immunosuppressive agent was used?",
    "context": "Start year of a third prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T296": {
    "name": "T296",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date the fourth corticosteroid/immunosuppressive agent was used?",
    "context": "Start month of a fourth prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T297": {
    "name": "T297",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date the fourth corticosteroid/immunosuppressive agent was used?",
    "context": "Start day of a fourth prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "T298": {
    "name": "T298",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date the fourth corticosteroid/immunosuppressive agent was used?",
    "context": "Start year of a fourth prior failed therapy for Sjögren's syndrome. Dependent on CB283 'Yes'."
  },
  "CB284": {
    "name": "CB284",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Was treatment with corticosteroids and other immunosuppressive agents not ineffective?",
    "context": "Evaluates success of prior therapy with corticosteroids or immunosuppressive agents for Sjögren's syndrome."
  },
  "CB299": {
    "name": "CB299",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
    "context": "Primary diagnostic criterion for refractory TTP, critical for justifying treatment."
  },
  "CB300": {
    "name": "CB300",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
    "context": "Primary diagnostic criterion for refractory TTP, impacting treatment approval."
  },
  "CB301": {
    "name": "CB301",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Does the patient have a documented diagnosis of Waldenström macroglobulinemia?",
    "context": "Primary diagnostic criterion for Waldenström macroglobulinemia, essential for treatment approval."
  },
  "CB302": {
    "name": "CB302",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Does the patient not have a documented diagnosis of Waldenström macroglobulinemia?",
    "context": "Primary diagnostic criterion for Waldenström macroglobulinemia, impacting treatment approval."
  },
  "CB303": {
    "name": "CB303",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is this a continuation request resulting from the patient receiving samples of Rituxan (rituximab)?",
    "context": "Indicates if the continuation request is based on prior Rituxan sample usage."
  },
  "CB304": {
    "name": "CB304",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is this a continuation request not resulting from the patient receiving samples of Rituxan (rituximab)?",
    "context": "Indicates if the continuation request is not based on prior Rituxan sample usage."
  },
  "T305": {
    "name": "T305",
    "type": "text",
    "page": 5,
    "field_label": "Please indicate the length of time on Rituxan (rituximab):",
    "question": "What is the length of time the patient has been on Rituxan (rituximab)?",
    "context": "Documents the duration of prior Rituxan therapy for continuation review."
  },
  "CB310": {
    "name": "CB310",
    "type": "checkbox",
    "page": 5,
    "field_label": "Mild",
    "question": "Is the severity of the disease at baseline (pretreatment with Rituxan) mild?",
    "context": "Baseline disease severity for rheumatoid arthritis, used to assess treatment efficacy."
  },
  "CB311": {
    "name": "CB311",
    "type": "checkbox",
    "page": 5,
    "field_label": "Moderate",
    "question": "Is the severity of the disease at baseline (pretreatment with Rituxan) moderate?",
    "context": "Baseline disease severity for rheumatoid arthritis, used to assess treatment efficacy."
  },
  "CB312": {
    "name": "CB312",
    "type": "checkbox",
    "page": 5,
    "field_label": "Severe",
    "question": "Is the severity of the disease at baseline (pretreatment with Rituxan) severe?",
    "context": "Baseline disease severity for rheumatoid arthritis, used to assess treatment efficacy."
  },
  "CB306": {
    "name": "CB306",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting rheumatoid arthritis disease stability?",
    "context": "Evidence of disease stability for rheumatoid arthritis to justify continuation of therapy."
  },
  "CB307": {
    "name": "CB307",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting rheumatoid arthritis disease stability?",
    "context": "Lack of evidence for disease stability for rheumatoid arthritis, impacting continuation review."
  },
  "CB308": {
    "name": "CB308",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting rheumatoid arthritis disease improvement?",
    "context": "Evidence of disease improvement for rheumatoid arthritis to justify continuation of therapy."
  },
  "CB309": {
    "name": "CB309",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting rheumatoid arthritis disease improvement?",
    "context": "Lack of evidence for disease improvement for rheumatoid arthritis, impacting continuation review."
  },
  "CB313": {
    "name": "CB313",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease stability for other indications?",
    "context": "Evidence of disease stability for non-RA indications to justify continuation of therapy."
  },
  "CB314": {
    "name": "CB314",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease stability for other indications?",
    "context": "Lack of evidence for disease stability for non-RA indications, impacting continuation review."
  },
  "CB315": {
    "name": "CB315",
    "type": "checkbox",
    "page": 5,
    "field_label": "Yes",
    "question": "Is there clinical documentation supporting disease improvement for other indications?",
    "context": "Evidence of disease improvement for non-RA indications to justify continuation of therapy."
  },
  "CB316": {
    "name": "CB316",
    "type": "checkbox",
    "page": 5,
    "field_label": "No",
    "question": "Is there no clinical documentation supporting disease improvement for other indications?",
    "context": "Lack of evidence for disease improvement for non-RA indications, impacting continuation review."
  },
  "T317": {
    "name": "T317",
    "type": "text",
    "page": 5,
    "field_label": "Date: (MM)",
    "question": "What is the month of the date the request was completed?",
    "context": "Month component of the prior authorization request completion date. Under H. ACKNOWLEDGEMENT."
  },
  "T318": {
    "name": "T318",
    "type": "text",
    "page": 5,
    "field_label": "Date: (DD)",
    "question": "What is the day of the date the request was completed?",
    "context": "Day component of the prior authorization request completion date. Under H. ACKNOWLEDGEMENT."
  },
  "T319": {
    "name": "T319",
    "type": "text",
    "page": 5,
    "field_label": "Date: (YYYY)",
    "question": "What is the year of the date the request was completed?",
    "context": "Year component of the prior authorization request completion date. Under H. ACKNOWLEDGEMENT."
  }
}